CompoSecure (CMPO) Form 144: 97,226 Shares Proposed Sale
CompoSecure, Inc. (CMPO) submitted a Form 144 notice for a proposed sale of 97,226 shares of Class A common stock, to be handled by Merrill Lynch (225 Liberty St, Floor 37, New York).
Rhea-AI Filing Summary
CompoSecure, Inc. (CMPO) submitted a Form 144 notice for a proposed sale of 97,226 shares of Class A common stock, to be handled by Merrill Lynch (225 Liberty St, Floor 37, New York). The filing reports an aggregate market value of $1,881,980.97 and shows 102,378,638 shares outstanding. The securities were acquired and are being sold following a broker-assisted exercise of employee stock options on 08/14/2025. The filing also discloses a recent sale by Gregoire Maes of 19,899 shares on 08/13/2025 for $383,293.75. The signer represents no undisclosed material adverse information exists regarding the issuer.
Positive
- Transparent disclosure of the proposed sale including broker, share count, market value, and dates
- Acquisition and sale method disclosed (broker-assisted exercise of employee stock options) which clarifies transaction nature
Negative
- Insider sale increases available shares for trading, which may affect perceived insider conviction
- No additional issuer context provided (no financials or rationale), limiting assessment of materiality beyond the transaction details
Insights
TL;DR: Insider exercised options and filed to sell 97,226 shares via Merrill Lynch; disclosure is routine but relevant to share supply.
The Form 144 shows an employee stock option exercise and immediate proposed sale of 97,226 Class A shares with an aggregate market value of $1,881,980.97. The filing provides counterparties and dates, and notes a prior sale by Gregoire Maes of 19,899 shares for $383,293.75. This is a standard Rule 144 disclosure that increases available free float for the issuer on the noted sale date but contains no financial performance data or new operational facts.
TL;DR: The notice documents compliant insider disposition after option exercise; governance disclosure obligations appear met.
The filer discloses acquisition via employee stock option exercise and a broker-assisted sale process, with explicit dates and amounts. The representation that no material nonpublic information is known by the seller is included. The form contains required signature and certification language; it does not report any governance actions, related-party transfers beyond the exercise, or plans that would imply unusual insider conduct.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CompoSecure (CMPO) report on Form 144?
Who is the broker handling the proposed sale?
Does the filer assert any undisclosed material information about the issuer?
AI-generated analysis. How Rhea-AI works. Not financial advice.